Upstate Active Clinical Trials

Study Title:

4941L: National Wilms Tumor Late Effects Study

What is the purpose of the study?

Screening study to determine if survivors from Wilms tumors or their offspring are at risk for adverse medical conditions.

Upstate Institutional Review Board (IRB) Number:

250899

Study/Protocol ID:

4941L

Study Phase:

N/A

Patient Age Group:

Children

Principal Investigator:

Karol H Kerr, MD

ClinicalTrials.Gov ID:

NCT00228696

For more information about this trial go to ClinicalTrials.Gov

Who can I contact for more information?

Name: Beatriz Kovar
Phone: 315-464-7232
Email: kovarb@upstate.edu

Return to Previous Page || Search Again